Checkpoint Inhibitor Shows Promise for Anal Cancer
People with well-controlled HIV on antiretroviral
therapy were eligible, making up 4% of the study population. Most patients
had previously received ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.